Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 3,960 | 2,581 | 2,030 | 2,979 | 2,630 |
| Operating Income | -3,960 | -2,581 | -2,030 | -2,979 | -2,630 |
| Other Income | 21 | 24 | 28 | 51 | 50 |
| Pre-tax Income | -3,939 | -2,556 | -2,003 | -2,928 | -2,580 |
| Income Tax | 7 | 0 | 0 | 0 | 5 |
| Net Income Continuous | -3,946 | -2,556 | -2,003 | -2,928 | -2,620 |
| Net Income | $-3,947 | $-2,556 | $-2,003 | $-2,928 | $-2,620 |
| EPS Basic Total Ops | -0.36 | -0.22 | -0.15 | -0.21 | -0.19 |
| EPS Basic Continuous Ops | -0.31 | -0.20 | -0.16 | -0.24 | -0.21 |
| EPS Diluted Total Ops | -0.36 | -0.22 | -0.15 | -0.21 | -0.19 |
| EPS Diluted Continuous Ops | -0.31 | -0.20 | -0.16 | -0.24 | -0.21 |
| EBITDA(a) | $-3,941 | $-2,548 | $-1,994 | $-2,946 | $-2,590 |